中文 | English
Return
Total: 24 , 1/3
Show Home Prev Next End page: GO
Author:( Xiaonan HONG)

1.Clinical characteristic and current status of treatment for nasal NK/T cell lymphoma

Biyun WANG ; Xiaonan HONG

China Oncology 2006;0(08):-

2.Endocrine system disturb induced by antineoplastic agents

Xin LIU ; Xiaonan HONG

China Oncology 2006;0(08):-

3.Advances in chemotherapy for upper gastrointestinal tumors

Ling DONG ; Xiaonan HONG

China Oncology 2001;0(05):-

4.Progress of the relationship between cyclooxygenase-2 and breast cancer

Xinmiao YANG ; Xiaonan HONG ; Xichun HU

China Oncology 2000;0(06):-

5.Phase Ⅱ clinical trial on docetaxel in the treatment of non-small-cell lung cancer

Wen ZHANG ; Jiliang YIN ; Xiaonan HONG

China Oncology 2000;0(06):-

6.Advances in dendritic cells vaccines

Fangfang LV ; Xiaonan HONG ; Jin LI

China Oncology 1998;0(01):-

7.Epidemiological features of metabolic syndrome in residents aged 20-80 years in Pudong New District of Shanghai

Liming YANG ; Xiaonan RUAN ; Yun BAI ; Qiao SUN ; Xiaojin FU ; Hong ZHANG ; Hua QIU ; Jianjun GU

Chinese Journal of Endocrinology and Metabolism 2011;27(9):718-723

8.Effects of Radiofrequency Ahlation of the Complicated Supraventricular Tachycardia

Lejin ZHOU ; Yunbo MIAO ; Jie FAN ; Hong XIE ; Xiaonan XU ; Bingyan LAN

Journal of Kunming Medical University 2001;22(1):83-86

9.The values of SOFA score, qSOFA score and SIRS criteria in predicting the prognosis of adult patients with suspect infection

Xiaonan ZHANG ; Hong ZHANG

Chinese Journal of Emergency Medicine 2018;27(3):259-264

10.The effect of expression level of IL-23R mRNA on Th17/IL-17 immune response in mycobacterium tuberculosis infection

Liu JIN ; Desheng ZHAO ; Heng ZHANG ; Zhiguo ZHANG ; Shuhui CAO ; Wei WANG ; Jun JIN ; Xiaonan ZHANG ; Hong SU

Chinese Journal of Disease Control & Prevention 2017;21(9):904-908

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 24 , 1/3 Show Home Prev Next End page: GO